Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
29.48
-0.17 (-0.57%)
Dec 5, 2024, 4:00 PM EST - Market closed
Artivion Market Cap
Artivion has a market cap or net worth of $1.24 billion as of December 5, 2024. Its market cap has increased by 113.22% in one year.
Market Cap
1.24B
Enterprise Value
1.54B
1-Year Change
113.22%
Ranking
Category
Stock Price
$29.48
Market Cap Chart
Since December 1, 1998, Artivion's market cap has increased from $143.30M to $1.24B, an increase of 762.39%. That is a compound annual growth rate of 8.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 4, 2024 | 1.24B | 69.36% |
Dec 29, 2023 | 733.90M | 50.14% |
Dec 30, 2022 | 488.80M | -38.93% |
Dec 31, 2021 | 800.40M | -12.75% |
Dec 31, 2020 | 917.40M | -9.70% |
Dec 31, 2019 | 1.02B | -3.16% |
Dec 31, 2018 | 1.05B | 63.74% |
Dec 29, 2017 | 640.70M | 1.86% |
Dec 30, 2016 | 629.00M | 105.09% |
Dec 31, 2015 | 306.70M | -3.13% |
Dec 31, 2014 | 316.60M | 3.40% |
Dec 31, 2013 | 306.20M | 79.06% |
Dec 31, 2012 | 171.00M | 26.57% |
Dec 30, 2011 | 135.10M | -11.41% |
Dec 31, 2010 | 152.50M | -16.53% |
Dec 31, 2009 | 182.70M | -33.13% |
Dec 31, 2008 | 273.20M | 24.81% |
Dec 31, 2007 | 218.90M | 14.91% |
Dec 29, 2006 | 190.50M | 135.77% |
Dec 30, 2005 | 80.80M | -51.03% |
Dec 31, 2004 | 165.00M | 44.74% |
Dec 31, 2003 | 114.00M | -14.73% |
Dec 31, 2002 | 133.70M | -76.39% |
Dec 31, 2001 | 566.30M | 0.23% |
Dec 29, 2000 | 565.00M | 292.63% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vir Biotechnology | 1.27B |
Progyny | 1.26B |
AdaptHealth | 1.26B |
Pediatrix Medical Group | 1.25B |
Pulse Biosciences | 1.25B |
Establishment Labs Holdings | 1.24B |
BioLife Solutions | 1.24B |
Rocket Pharmaceuticals | 1.23B |